Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study will examine a sequence of treatments including pre-operative chemotherapy and
radiation, surgery and post-operative chemotherapy for resectable pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center
Collaborators:
Johns Hopkins University Ohio State University Princess Margaret Hospital, Canada Sanofi